Patent Number: 7,820,405

Title: Specific bacterial inclusions in bone marrow cells indicate systematic lupus erthematosus, and treatment for lupus

Abstract: A method for diagnosing for the presence of systemic lupus erythematosus (SLE) in a patient is disclosed. In accordance with this method, megakaryocytes present in bone marrow of a person suspected of having SLE are assayed for the presence of internal bacterial structures that specifically stain with an intercalating dye. The presence of those specifically stainable structures within the patient's megakaryocytes indicates that the patient has SLE. Treatment of an SLE patient with an antibiotic is contemplated. Treatment of a patient that has SLE comprises administering to that patient (i) an antibacterial amount of a rifamycin along with an antibacterial amount of a macrolide, (ii) an antibacterial amount of a tetracycline, or (iii) an antibacterial amount of a quinolone, or a mixture of two or more of i, ii and iii. The treatment is continued until the patient's megakaryocytes no longer contain specifically stainable structures, and until no further evidence of infection is present.

Inventors: Kallick; Charles A. (Lemont, IL)

Assignee: Sphingomanas Research Partners, L.P.

International Classification: C12Q 1/04 (20060101); C12Q 1/02 (20060101); C12Q 1/00 (20060101)

Expiration Date: 2018-10-26 0:00:00